Mirna secreted in vesicles allow atheroprotective communication in vessel wall;Protection des vaisseaux sanguins contre l'athérosclérose le rôle des miarn sécrétés par l'endothélium

Medecine/Sciences

Volumn 28, Issue 6-7, 2012, Pages 584-587

  Tréguer, Karine ^a,b   Heydt, Susanne ^a   Hergenreider, Eduard ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CNRS Bordeaux Segalen University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864068680     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2012286010     Document Type: Short Survey

References (18)

1. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035-42.
2. Boon RA, Horrevoets AJ. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 2009;29:39-40.
3. Kuo CT, Veselits ML, Barton KP, et al. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev 1997;11:2996-3006.
4. Lee JS, Yu Q, Shin JT, et al. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell 2006;11:845-57.
5. Wu J, Bohanan CS, Neumann JC, Lingrel JB. KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. J Biol Chem 2008;283:3942-50.
6. Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012;14:249-56.
7. Bartel D P. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
8. Bonauer A, Boon RA, Dimmeler S. Vascular microRNAs. Curr Drug Targets 2010;11:943-9.
9. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 2011;4:197-205.
10. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010;56:1733-41.
11. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-37.
12. Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 2011;31:2383-90.
13. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012;110:483-95.
14. Weickmann JL, Glitz DG. Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine, and organ preparations. J Biol Chem 1982;257:8705-10.
15. Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010;38:7248-59.
16. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108:5003-8.
17. Patrice Dunoyer. La bataille du silence: mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 25;5:505-12.
18. Ladeiro Y, Zucman-Rossi J. Micro-ARN (miARN) et cancer: le cas des tumeurs hépatocellulaires. Med Sci (Paris) 25;5:467-72.